Parvin Asset Management LLC bought a new position in shares of The Campbell’s Company (NASDAQ:CPB – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 29,285 shares of the company’s stock, valued at approximately $652,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. OVERSEA CHINESE BANKING Corp Ltd bought a new position in Campbell’s in the 2nd quarter valued at about $779,000. Comprehensive Financial Planning Inc. PA bought a new stake in Campbell’s during the 2nd quarter worth approximately $31,000. Citizens Financial Group Inc. RI bought a new stake in Campbell’s during the 2nd quarter worth approximately $273,000. Commerzbank Aktiengesellschaft FI purchased a new stake in shares of Campbell’s in the second quarter worth approximately $878,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Campbell’s in the second quarter worth approximately $79,090,000. Institutional investors and hedge funds own 52.35% of the company’s stock.
Campbell’s Trading Down 1.0%
Shares of CPB stock opened at $23.23 on Thursday. The company has a 50 day moving average of $22.53 and a 200-day moving average of $22.60. The company has a quick ratio of 0.38, a current ratio of 0.87 and a debt-to-equity ratio of 1.53. The Campbell’s Company has a 12-month low of $19.56 and a 12-month high of $34.17. The firm has a market cap of $6.93 billion, a P/E ratio of 11.50 and a beta of 0.02.
Analysts Set New Price Targets
Several research analysts recently issued reports on the company. Stifel Nicolaus lifted their target price on Campbell’s from $20.00 to $22.00 and gave the company a “hold” rating in a research report on Wednesday, July 22nd. Sanford C. Bernstein reissued an “underperform” rating and issued a $19.00 price target (down from $21.00) on shares of Campbell’s in a research report on Tuesday, June 9th. Stephens cut Campbell’s from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $28.00 to $21.00 in a research note on Monday, June 1st. JPMorgan Chase & Co. lifted their price objective on shares of Campbell’s from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Finally, Morgan Stanley reduced their target price on shares of Campbell’s from $23.00 to $21.00 and set an “equal weight” rating for the company in a research note on Friday, June 5th. Twelve research analysts have rated the stock with a Hold rating and seven have given a Sell rating to the company. According to data from MarketBeat.com, Campbell’s currently has an average rating of “Reduce” and a consensus target price of $20.40.
View Our Latest Analysis on CPB
Campbell’s Company Profile
Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
See Also
- Five stocks we like better than Campbell’s
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding CPB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Campbell’s Company (NASDAQ:CPB – Free Report).
Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.
